Clinical Trial Update: Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating eptinezumab as an adjunct to standard-of-care for acute emergency migraine, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• VYEPTI (eptinezumab)

Snippet

Sponsor: Dr George Medvedev | Conditions: Migraine, Chronic Migraine | Phase 3 | Status: NOT_YET_RECRUITING